Advances in therapeutic CRISPR/Cas9 genome editing

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Genome editing tools are crucial for genetic research and therapy.
• The CRISPR/Cas9 system has rapidly advanced the field of genome editing.
• CRISPR/Cas9 offers high specificity and efficiency in DNA modification.

Purpose of the Study:

• To review preclinical studies utilizing CRISPR/Cas9 for gene therapy.
• To discuss the therapeutic potential of CRISPR/Cas9 in clinical applications.
• To summarize recent advancements in CRISPR/Cas9-mediated disease allele modulation.

Main Methods:

• Review of recent scientific literature on CRISPR/Cas9 applications.
• Analysis of studies reporting in vivo and ex vivo CRISPR/Cas9 gene editing.
• Focus on preclinical gene therapy reports for various diseases.

Main Results:

• CRISPR/Cas9 has been successfully used to modulate disease-causing alleles in animal models.
• Ex vivo applications in somatic and induced pluripotent stem cells show promise.
• Preclinical studies demonstrate the feasibility of CRISPR/Cas9 for therapeutic genome editing.

Conclusions:

• CRISPR/Cas9 technology holds significant promise for future clinical gene therapies.
• The ease of guide RNA design and system efficiency contribute to its success.
• Ongoing preclinical research is paving the way for in-human therapeutic applications.